Dehydroevodiamine

Research use only, not for human use.

Dehydroevodiamine, a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.

Dehydroevodiamine, a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.

Dehydroevodiamine (0-50 μM; 2 hours) inhibits iNOS and COX-2 expressionand prevents degradation of IκB-α in LPS induced RAW 264.7 macrophages. Dehydroevodiamine (0-50 μM; 2 hours) inhibits a LPS-induced increase in the iNOS and COX-2 mRNA expression.Western Blot Analysis Cell Line:RAW 264.7 macrophage cells Concentration:10 μM, 30 μM, 50 μM Incubation Time:pretreated 2 hours Result:Reduced iNOS and COX-2 expression and increased IκB-α expression.RT-PCR Cell Line:RAW 264.7 macrophage cells Concentration:10 μM, 30 μM, 50 μM Incubation Time:pretreated 2 hours Result:Reduced iNOS and COX-2 mRNA expression.

——

——

GPCR/G Protein

Dopamine Receptor

Others

Others-Field

——

67909-49-3

301.34

C19H15N3O

>98% (HPLC)

In Vitro:?DMSO : 8.33 mg/mL (27.64 mM)

CN1C2=CC=CC=C2C(=O)N3C1=C4C(=C5C=CC=CC5=N4)CC3

——

(-20℃)

With Ice Pack

≥ 2 years